Gary has extensive experience in corporate strategy, business development, building healthcare companies and raising capital from top-tier investors. Gary is currently a Senior Advisor to numerous Med Tech start-up companies. 

Most recently, Gary was the Chief Business Officer at Breathe Technologies where he successfully raised significant venture capital from investors including Kleiner Perkins, Deerfield Management, Partner Fund and Johnson & Johnson. 

He was also instrumental in developing and executing the company’s strategy to create significant value, navigating the FDA and CMS, to bring breakthrough technologies to market. He supported the companies growth from 5 employees to more than 80 and secured sales contracts that have provided a pathway for the company to become one of the fastest growing med tech manufacturers. 

Previously, he worked closely on a number of M&A transactions, including the $900 million sale of Ovation Pharmaceuticals to H. Lundbeck A/S and the $150 million acquisition of Prestwick Pharmaceuticals. 

Gary started his career in investment banking and moved to management consulting, where he worked with many Fortune 500 companies.

 

About Breathe Technologies: Breathe Technologies, Inc. is a developer and manufacturer of innovative medical technologies for patients with respiratory insufficiency and neuromuscular diseases. The company manufactures the Life2000™ Ventilation System, the first truly wearable ventilator on the market that provides continuous ventilation and supports improved patient mobility.Headquartered in Irvine, California, Breathe Technologies has a robust product pipeline dedicated to enabling healthier living across the entire continuum of care and addressing additional unmet needs in respiratory care.